相关实验视频

Updated: Jun 9, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

427

针对SARS的药物发现前景 冠状病毒甲基转移酶:功能,结构和抑制

Xin Li, Yongcheng Song

    Journal of medicinal chemistry
    |October 31, 2024
    PubMed
    概括

    针对病毒甲基转移酶的新疗法对于对抗SARS-CoV-2和未来的冠状病毒威胁至关重要. 本综述探讨了甲基转移酶的功能,结构和抑制,以开发有效的抗病毒药物.

    更多相关视频

    Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source08:35

    Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

    Published on: May 29, 2021

    5.1K
    Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit22:10

    Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

    Published on: June 28, 2013

    13.2K

    相关概念视频

    Structure-Activity Relationships and Drug Design01:28

    Structure-Activity Relationships and Drug Design

    Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
    SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
    611
    Targets for Drug Action: Overview01:26

    Targets for Drug Action: Overview

    Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
    Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
    6.0K